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Abstract
Background: World Health Organization/International Society of Hypertension (WHO/ISH) charts have been 
employed to predict the risk of cardiovascular outcome in heterogeneous settings. The aim of this research is 
to assess the prevalence of Cardiovascular Disease (CVD) risk factors and to estimate the cardiovascular risk 
among adults aged >40 years, utilizing the risk charts alone, and by the addition of other parameters.
Methods: A cross-sectional study was performed in two of the villages availing health services of a medical 
college. Overall 570 subjects completed the assessment. The desired information was obtained using a pre-
tested questionnaire and participants were also subjected to anthropometric measurements and laboratory 
investigations. The WHO/ISH risk prediction charts for the South-East Asian region was used to assess the 
cardiovascular risk among the study participants. 
Results: The study covered 570 adults aged above 40 years. The mean age of the subjects was 54.2 (±11.1) 
years and 53.3% subjects were women. Seventeen percent of the participants had moderate to high risk for the 
occurrence of cardiovascular events by using WHO/ISH risk prediction charts. In addition, CVD risk factors 
like smoking, alcohol, low High-Density Lipoprotein (HDL) cholesterol were found in 32%, 53%, 56.3%, and 
61.5% study participants, respectively. 
Conclusion: Categorizing people as low (<10%)/moderate (10%-20%)/high (>20%) risk is one of the crucial 
steps to mitigate the magnitude of cardiovascular fatal/non-fatal outcome. This cross-sectional study indicates 
that there is a high burden of CVD risk in the rural Pondicherry as assessed by WHO/ISH risk prediction charts. 
Use of WHO/ISH charts is easy and inexpensive screening tool in predicting the cardiovascular event. 
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Implications for policy makers
• The result of this study can be utilized by the policy-makers to universally incorporate the use of World Health Organization/International 
Society of Hypertension (WHO/ISH)  Cardiovascular Disease (CVD) risk charts in predicting the risk of any fatal outcome.
• The policy-makers can plan and fund more studies on a major scale in their local settings, in order to approximate the probability of risk in 
the local population.
Implications for public
It has been well documented that the use of the total Cardiovascular Disease (CVD) risk approach can significantly minimize the involved 
expenditure in contrast to the use of individual risk parameters. As these risk charts are graphical and easy to understand, the general population 
can be explained about their individual risk, and hence motivated to adopt necessary preventive measures to delay any untoward outcome.
Key Messages 
Background 
For many years, diseases of infectious origin are the leading 
cause accounting for mortality, especially in resource-
constraint settings (1). However, in the past few decades owing 
to urbanization/globalization, increased life expectancy, 
and adoption of harmful lifestyles, Non-Communicable 
Diseases (NCDs), especially Cardiovascular Disease (CVD) 
has emerged as one of the leading cause of morbidity, early 
death, overburdening of the public health infrastructure, and 
escalating direct/indirect healthcare costs throughout the 
world (2–4).
CVD results secondary to the abnormalities in the 
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cardiovascular system, and includes a wide spectrum of 
disorders (5). Despite the reduction in the incidence of 
Coronary Heart Disease (CHD) in developed nations, the 
scenario in developing nations poses a serious challenge (6). 
CVD generally results from the interplay of a wide range 
of genetic, socio-economic, individual, physician-related, 
environmental factors, and healthcare delivery system-related 
factors (2,3,5–12). These risk factors have been targeted in 
separate high-risk groups and in community settings and 
encouraging results have been obtained (13,14).
In view of the interplay of multiple factors in the etiology 
of CVDs, it will be wrong to adopt a single risk factor for 
predicting cardiovascular risk (2–11,15). In fact, the best 
approach will be to adopt a particular risk chart which 
considers a maximum number of all probable determinants 
so that the contribution of each of the risk factors can be 
ascertained in different regions (15–17). The total risk 
approach was initially implemented in the developed nations 
and subsequently they have been employed in other parts 
of the world after adjustments (16–18). The World Health 
Organization (WHO) and the International Society of 
Hypertension (ISH) have formulated CVS risk prediction 
charts for use in different sections of the globe using the best 
available mortality and risk factor data (15,19). The proposed 
chart is a cost-effective tool to stratify the entire population 
using a risk score and thus presents a ten-year risk of major 
cardiovascular outcome in 14 of the WHO epidemiological 
sub-regions. Hence, it is a useful tool to counsel patients to 
modify their lifestyles or comply with their medicines (19). 
We have adopted WHO/ISH cardiovascular risk prediction 
charts in the current study and not the General Framingham 
Risk Profile (GFRP) because of the augmentation of risk in 
wide group of population (20,21). The WHO/ISH charts 
are designed to aid the clinicians in implementing timely 
preventive measures to improve the life expectancy, quality of 
life of the risk groups and reduction in the burdening of the 
health system (4,13,19).
The present study was conducted to assess the prevalence of 
CVS risk parameters and to estimate the cardiovascular risk 
among adults aged >40 years, using the WHO/ISH risk charts 
alone, and with the addition of other parameters.
Methods
A cross-sectional study was performed from November 2011 
to January 2012. As per the report of the Census 2011, the 
Union territory of Pondicherry has a total population of 1.25 
million (22).
 
Study population
Of the three villages under the rural health centre, two villages 
– Ramanathapuram (population 2,165) and Pillaiyarkuppam 
(population 2,412) were chosen purposively for the study 
as they were closer to the centre, and they would facilitate 
collecting fasting blood samples in the early mornings. The 
sample size was estimated using OpenEpi version 2.3.10. To 
detect the prevalence of 5.8% of diabetes (CVD risk factor with 
the lowest prevalence) with 2% absolute precision, minimum 
sample needed was 525 (23). Taking into consideration a non-
response rate of 25%, it was decided to study 705 subjects. 
The study sample included persons above 40 years (N= 1,279) 
of age and cluster sampling method was used. Pilot study 
showed that if individual subjects were chosen by random or 
systematic random sampling method, there was dissatisfaction 
among the people who were left out in the community. Hence, 
instead of individual subjects, streets were considered as the 
units of sampling. Thus, four out of nine streets were selected 
from each village randomly using lots.
Inclusion and exclusion criteria
From the houses of the selected streets, all participants 
aged more than 40 years (n= 705) were invited to take part 
in the study. Subjects unavailable during home visits on 
three separate days (n= 128) and those who did not wish to 
participate in the study (n= 7) were excluded. In addition, 
those individuals with confirmed atherosclerotic CVD were 
excluded from the study. In total, 570 subjects participated in 
the assessment. 
Study tool
After obtaining the verbal informed consent, study 
participants were interviewed face-to-face using a semi-
structured questionnaire. The questionnaire was pre-tested 
on a group of 30 individuals before its utilization. Also, 
each of the participants were subjected to anthropometric 
measurements (i.e. height, weight, and waist circumference); 
assessment of blood pressure, and laboratory investigations 
(lipid profile, estimation of fasting and postprandial blood 
glucose). Lipid profile was measured using fasting blood 
samples of the study subjects with the help of an Olympus 
AU400 auto analyzer while glucometer was used for the blood 
glucose measurement. The set cut-off values for lipid profile 
were as follows, total cholesterol <200 mg/dl, triglycerides 
<150 mg/dl, Low-Density Lipoprotein (LDL) <130 mg/dl and 
High-Density Lipoprotein (HDL) >40 mg/dl for males and 
>50 mg/dl for females (24). The WHO/ISH cardiovascular risk 
prediction charts for the South-East Asian region was used to 
assess the cardiovascular risk among the study participants 
(19). The predictor variables for the risk prediction were age, 
gender, smoking, blood pressure, coexistence of diabetes, and 
serum cholesterol level.
Operational definitions
Education status was categorized as no schooling and 
attended school (25). For the categorization of the work status 
(viz. employed and unemployed) guidelines of Census 2001, 
recommended by the Government of India were utilized 
(26). BG Prasad modified classification was employed for 
classifying the study population as per their socio-economic 
status (27). Physical activity was categorized based on the 
total Metabolic Equivalents/week (MET/week) as physically 
inactive (<600 MET/week) and physically active (≥600 MET/
week) (28). Smoking was defined as the use of any smoke 
form of tobacco product in the last six months (29). Alcohol 
use was defined as consumption of any type of alcohol in the 
last one year (29). These were further classified as abstainers 
(never consumed alcohol in past 12 months), grade 1 (<39.9 
gm/day), grade 2 (40 to 59.99 gm/day) and grade 3 (>60 
gm/day) (30). Study participants were classified as diabetics 
based on the guidelines proposed by Indian Council of 
Medical Research (ICMR) [fasting blood sugar (>125 mg/dL) 
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and/or postprandial blood sugar (>200 mg/dL)] (30,31). 
Furthermore, those individuals who were under treatment 
with oral hypoglycemic agents/insulin were also labeled as 
diabetic irrespective of their blood glucose status. Subjects 
were diagnosed to be hypertensive (if systolic blood pressure 
≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg or 
taking antihypertensive medication).
Height was recorded in standing position with subject’s shoes 
and socks removed prior to measurement. The subject was 
asked to stand straight on a plane floor so that his heels, 
buttock and shoulder are in contact with vertical wall. The 
heels were placed together so that the medial malleoli touch 
each other. Subject was asked to relax his shoulder and to keep 
hands and arm loose and relaxed with palm facing medially. 
The head was positioned in the Frankfrut plane. The height 
was measured in centimeters with the help of a measuring 
tape (32). 
Waist circumference was measured at a level midway between 
the lowest rib and the iliac crest using microtoise tape with 
sensitivity of 0.1 cm. Subjects with a waist circumference 
of ≥102 cm (male) and ≥88 cm (females) were said to have 
abdominal or truncal obesity. Weight was measured using 
digital weighing machine by United Nations Children’s 
Fund (UNICEF) with sensitivity of 100 g. The subjects were 
weighed in minimal clothing without shoes. Weight was 
recorded in kilogram. Before each reading, it was ensured 
that the equipment was properly placed and checked for zero 
balance (32). 
Blood pressure was measured using a digital blood 
pressure monitor (Omron, SEM-1, Japan) by using 
the oscillometric technique as recommended by NCD 
surveillance of Integrated Disease Surveillance Project 
(IDSP), Government of India. It was measured in right upper 
limb in supine position or sitting on a chair with back straight 
and with arm resting on a table at the level of the heart with 
appropriate size cuff. The first reading of blood pressure was 
taken after 5 minutes of rest and the second reading was 
taken at the end of interview, i.e. after 10 minutes. The second 
reading was taken as the final reading (33).
Body Mass Index (BMI) was calculated by obtaining the ratio 
of weight (kg)/height2 (m) and study subjects were classified 
as underweight (<18.5 kg/m2), normal (18.5–22.99 kg/m2), 
overweight (23–24.99 kg/m2) and obese (≥25 kg/m2) (34).
 
Statistical analysis
The collected data was entered in Microsoft Excel. Data were 
analyzed by the SPSS version 16.0 for Windows (SPSS Inc., 
Chicago, IL, USA). Frequency distributions and percentages 
were computed for all the variables. The association between 
various study categorical variables and gender was calculated 
by using Chi-Square test. All P-values were two tailed and 
significant when values were less than 0.05. 
Results
The mean age of the subjects was 54.2 (±11.1) years with 
53.3% subjects being women. Table 1 reveals the association 
between different socio-demographic/study variables and the 
gender of the study subjects. Most of the study participants, 
234 (41%) were from the age group of 40–49 years, followed 
by 178 (31.2%) of the 50–59 years. The higher proportion of 
Table 1. Characteristics of study participants
Study variables Women (%) Men (%) P-value
Total 304 (53.3) 266 (46.7) -
Age in years 0.521
40–49 125 (41.1) 109 (41.0)
50–59 100 (32.9) 78 (29.3)
60–69 46 (15.1) 52 (19.5)
>69 33 (10.9) 27 (10.2)
Educational status <0.001
No schooling 184 (60.5) 63 (23.7)
Attended school 120 (39.5) 203 (76.3)
Occupational status <0.001
Non-workers 148 (48.7) 55 (20.7)
Worker 156 (51.3) 211 (79.3)
Per capita income 0.867
≤3100 INR (≤ US$49.3) 280 (92.1) 246 (92.5)
>3100 INR (> US$49.3) 24 (7.9) 20 (7.5)
Physical activity status 0.616
Inactive 30 (9.9) 23 (8.6)
Active 274 (90.1) 243 (91.4)
BMI (kg/m2) 0.616
<23 197 (64.8) 167 (62.8)
≥23 107 (35.2) 99 (37.2)
Waist circumferencea (cm) 0.024
Normal 190 (62.5) 190 (71.4)
High risk 114 (37.5) 76 (28.6)
Blood pressureb (mm Hg) 0.123
Normal 229 (75.3) 185 (69.5)
Above normal 75 (24.7) 81 (30.5)
Diabetesc 0.132
Absent 259 (85.2) 214 (80.5)
Present 45 (14.8) 52 (19.5)
Total cholesterol (mg/dl) 0.682
Normal (<200 mg/dl) 224 (73.7) 200 (75.2)
High (>200 mg/dl) 80 (26.3) 66 (24.8)
BMI= Body Mass Index.
a Normal (<102 cm for males and <88 cm for females).
b Normal (systolic blood pressure <139 mm Hg and diastolic blood 
pressure <89 mm Hg).
c Present [(fasting blood sugar (>125 mg/dL) and/or postprandial blood 
sugar (>200 mg/dL)].
Table 2. Risk of CVD with different inclusion criteria for the risk factors
Inclusion criteria
CVD Risk
Low (%)
(<10%)
Moderate (%) 
(10%–20%)
High (%)
(>20%)
Chart + BP 160/100 + 
Cholesterol ≥8 mmol/l
473
(83.0)
39
(6.8)
58 
(10.2)
CVD= Cardiovascular Disease.
women did not attend the school and were non-worker as 
compared to the men (P= 0.001). One-third of the subjects 
were obese with no gender preponderance. In addition, 
abdominal obesity was present in 114 (37.5%) women 
compared to 76 (28.6%) men, P= 0.024.
Table 2 demonstrates the distribution of CVD risk based on 
the employment of distinctive characteristics in combination. 
Using chart alone, 86.0% subjects were predicted to have a 
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low risk (<10%) of the CVD event in 10 years duration. Only 
7 people (4 men and 3 women) had a risk >30%, so to see 
the stratified prevalence of CVD risk by gender, the cutoff 
for the high risk was taken as a CVD risk above 20%. The 
CVD risk was more among males than in females (P= 0.017). 
The prevalence of low, moderate and high CVD risk in the 
men was 82.7%, 12.8%, and 4.5%, while in the women the 
prevalence was 88.8%, 5.9%, and 5.3%, respectively. By 
application of additional criteria for blood pressure and 
cholesterol, the subjects with low risk were reduced to 83%. 
However, it was found that 6.8% and 10.2% subjects had 
moderate (10%–20%) and high risk (>20%) of CVD-related 
outcome. 
The study population showed higher prevalence of obesity 
(36.1%), abdominal obesity (33.4%), smoking (32.0%), and 
alcohol usage (53.0%; Table 3). Diet of the most participants 
was low in calorie, but was high in salt. Similarly, other 
CVD risk conditions like diabetes (17.0%) and hypertension 
(27.4%). Of the lipid parameters, a higher proportion of 
subjects had lower than the recommended HDL level (56.3%) 
followed by high total cholesterol (25.6%), high LDL (22.5), 
and high TGL (20.7%). 
The prevalence of the risk factors was stratified by the CVD 
risk (as mild, moderate and high). The risk predictors used to 
calibrate the CVD risk (viz. smoking, diabetes, hypertension, 
and high total cholesterol) showed a higher prevalence of a 
fatal outcome in the next decade, as the CVD risk worsened. 
It was observed that in the higher CVD risk group, maximum 
prevalence was of hypertension (86.2%) followed by excessive 
salt intake (70.7%). For the same group, high prevalence was 
noted for alcohol use (61.5%) and low HDL (50.0%). In the 
moderate CVD risk category, almost half of the subjects were 
tobacco and alcohol users and had a low HDL. 
Discussion
It has been well documented that the eventual outcome 
of myocardial infarction/stroke/death rarely precipitates 
because of a single potential risk factor, but more often 
because of the combined effect of several risk factors (35,36). 
Studies have revealed that the cardiovascular risk evaluation 
by general practitioners is limited and thus there is immense 
need to enhance their awareness of the same (12,36). 
In the current study, different socio-demographic and 
biochemical parameters have been assessed to identify their 
association with the study population. It has been found that 
level of education, employment status and waist circumference 
of the study participants was statistically associated with the 
gender of the study subjects. Findings of an epidemiological 
study performed in northern India revealed that no 
gender differences was present with regard to parameters 
like physical inactivity, central obesity, overweight, and 
hypertension (9). However, another study done to assess the 
associations between socio-economic parameter and CVD 
risk factors among urban and rural South Indians, showed 
contrasting results, with a significant statistical association 
being observed with factors like hypertension, deranged lipid 
profile, abdominal obesity, and parental education status (10).
Multiple studies across the world have utilized the WHO/ISH 
cardiovascular risk prediction charts to estimate the risk in 
heterogeneous settings (14,37,38). In contrast, findings of a 
study reflected that the WHO/ISH charts were incorrect to 
discriminate the risk in Malaysian population (39). The WHO 
has recommended that in low-resource settings, measures 
like individual counseling should be made available based on 
the extent of cardiovascular risk (4,40). In the present study, 
high risk was found to be 4.9% by utilizing WHO/ISH risk 
prediction charts. Various studies have revealed a variable 
level of prevalence of CVD risk using the similar WHO/ISH 
risk prediction charts in some of the Asian countries (viz. 
China 1.1%, Iran 1.7%, Sri Lanka 2.2%, Nepal 9.8%, and 
Pakistan 10.0%) (41,42). A combination of three criteria of a 
chart, high blood pressure and high serum cholesterol; 10.2% 
subject had a moderate or high risk of CVD event. It signifies 
the proportion of the subjects who needs intensive lifestyle 
interventions and appropriate pharmacological management. 
The CVD risk was found to be less when compared with the 
Cambodia (11.2%) and Malaysia (21.5%) (43). In fact, these 
risk prediction charts have been identified as a key tool in the 
Table 3. Prevalence of NCD risk factors in the CVD risk groups
Risk factors
CVD risk
Total
Mild (%) (<10%) Moderate (%) (10%-20%) High (%) (>20%)
Total (n) 473 39 58 570
Physical inactivity 7.6 (5.5-10.3) 15.4 (6.5-29.3) 19.0 (10.4-30.6) 9.3 (7.1-11.9)
BMI (≥23 kg/m2) 35.9 (31.7-40.3) 30.8 (17.9-46.4) 41.4 (29.3-54.3) 36.1 (32.3-40.2)
Abdominal obesity 32.6 (28.5-36.9) 33.3 (20.0-49.1) 39.7 (27.7-52.6) 33.4 (29.6-37.3)
Smoking 28.0 (22.2-34.3) 58.6 (40.3-75.3) 34.6 (18.4-54.1) 32.0 (26.6-37.7)
Tobacco chewing 22.8 (19.2-26.8) 48.7 (33.4-64.2) 20.7 (11.7-32.5) 24.4 (21.0-28.0)
Alcohol usage 52.1 (45.4-58.8) 51.7 (33.8-69.3) 61.5 (42.1-78.6) 53.0 (47.0-59.0)
High calorie intake 4.1 (2.5-6.1) 5.1 (0.9-16.0) 5.3 (1.3-13.4) 4.3 (2.8-6.1)
High salt intake 62.1 (57.7-66.5) 41.0 (26.5-56.9) 70.7 (58.1-81.3) 61.5 (57.5-65.5)
Hypertension 18.6 (15.3-22.3) 46.2 (31.1-61.8) 86.2 (75.5-93.4) 27.4 (23.8-31.1)
Diabetes 13.7 (10.9-17.1) 28.2 (15.8-43.7) 36.2 (24.6-49.1) 17.0 (14.1-20.3)
Total cholesterol (mg/dl) 22.6 (19.0-26.6) 41.0 (26.5-56.9) 39.7 (27.7-52.6) 25.6 (22.2-29.3)
High triglyceride (mg/dl) 19.2 (15.9-23.0) 17.9 (8.2-32.3) 34.5 (23.1-47.4) 20.7 (17.5-24.2)
High LDL (mg/dl) 20.1 (16.7-23.9) 30.8 (17.9-46.4) 36.2 (24.6-49.1) 22.5 (19.2-26.0)
Low HDL (mg/dl) 57.7 (53.2-62.1) 48.7 (33.4-64.2) 50.0 (37.3-62.7) 56.3 (52.2-60.4)
NCD= Non-communicable disease; CVD= Cardiovascular Disease; BMI= Body Mass Index; LDL= Low-Density Lipoprotein; HDL= High-Density Lipoprotein.
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successful implementation of the NCD action plan (44).
In the current study, high salt intake (62.1%), tobacco 
chewing (48.7%), and alcohol use (51.7%) were recorded as 
the risk factors with maximum prevalence in the mild and 
moderate risk groups, respectively. While in the high-risk 
group, prevalence was higher for low HDL (50.0%), alcohol 
usage (61.5%), high salt intake (70.7%), and hypertension 
(86.2%). In a study done among the sedentary workers in 
an Indian city, the major risk factors for CHD were elevated 
triglycerides, hypertension, and high levels of serum total 
cholesterol (45). The probable reason for such results is 
because of the sedentary lifestyle and higher prevalence of 
central obesity among them (42).
These findings point that although WHO/ISH risk charts 
are a handy and simple tool for CVD risk prediction, but 
may underestimate the CVD risk burden. The CVD risk 
factors relevant to the Asian context like obesity, abdominal 
obesity, family history of CVDs, tobacco chewing, high salt 
intake, and NCD treatment status are not part of the current 
risk prediction chart. It is the need of the hour to develop a 
comprehensive risk prediction chart for Asian population 
including these risk factors. Finally, it is also recommended to 
assess the treatment outcome based on the total CVD risk as 
estimated by the WHO/ISH risk charts.
As the present study was conducted in two of the villages of 
rural Pondicherry (viz. sample size being small) and thus 
findings of the study cannot be generalized to the other 
populations.
Conclusion
Categorizing people as low (<10%) / moderate (10%–20%) / 
high (>20%) risk is one of the crucial steps to mitigate the 
magnitude of cardiovascular fatal/non-fatal outcome. This 
cross-sectional study indicates that there is significant burden 
of CVD risk in the rural Pondicherry as assessed by WHO/
ISH risk prediction charts. 
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